Literature DB >> 2541544

Analysis of the fowlpoxvirus gene encoding the 4b core polypeptide and demonstration that it possesses efficient promoter sequences.

M M Binns1, M E Boursnell, F M Tomley, J Campbell.   

Abstract

The gene encoding the fowlpox virus 4b core polypeptide has been identified by analogy with the vaccinia 4b gene. It has been cloned, and its nucleotide sequence determined. The gene, which is 1971 nucleotides long, can encode a protein of 75,200 Da (75.2K polypeptide), slightly longer than its vaccinia counterpart with which it shares 52% identity. Sequences upstream of the fowlpox virus 4b gene correspond to the consensus sequence determined for vaccinia late promoters, suggesting that late promoter signals may be shared by the different genera of poxviruses. Upstream sequences have been cloned into a beta-galactosidase translational fusion vector and shown to promote the efficient expression of beta-galactosidase in a transient assay system. This expression was abolished in the presence of araC, an inhibitor of DNA replication which blocks late gene expression in poxviruses. The fowlpoxvirus 4b promoter should be a useful component of genetically engineered fowlpox virus vaccines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541544     DOI: 10.1016/0042-6822(89)90380-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Worldwide phylogenetic relationship of avian poxviruses.

Authors:  Miklós Gyuranecz; Jeffrey T Foster; Ádám Dán; Hon S Ip; Kristina F Egstad; Patricia G Parker; Jenni M Higashiguchi; Michael A Skinner; Ursula Höfle; Zsuzsa Kreizinger; Gerry M Dorrestein; Szabolcs Solt; Endre Sós; Young Jun Kim; Marcela Uhart; Ariel Pereda; Gisela González-Hein; Hector Hidalgo; Juan-Manuel Blanco; Károly Erdélyi
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

2.  The genome of fowlpox virus.

Authors:  C L Afonso; E R Tulman; Z Lu; L Zsak; G F Kutish; D L Rock
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Activity of a fowlpox virus late gene promoter in vaccinia and fowlpox virus recombinants.

Authors:  S Kumar; D B Boyle
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  The 131-amino-acid repeat region of the essential 39-kilodalton core protein of fowlpox virus FP9, equivalent to vaccinia virus A4L protein, is nonessential and highly immunogenic.

Authors:  D Boulanger; P Green; T Smith; C P Czerny; M A Skinner
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  trans processing of vaccinia virus core proteins.

Authors:  P Lee; D E Hruby
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

6.  Role of the TK+ phenotype in the stability of pigeonpox virus recombinant.

Authors:  C Letellier
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Recombinant fowlpox viruses expressing the glycoprotein B homolog and the pp38 gene of Marek's disease virus.

Authors:  N Yanagida; R Ogawa; Y Li; L F Lee; K Nazerian
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

8.  Vaccination of chickens with a recombinant fowlpox virus containing the hemagglutinin-neuraminidase gene of Newcastle disease virus under the control of the fowlpox virus thymidine kinase promoter.

Authors:  E Nagy; P J Krell; R A Heckert; J B Derbyshire
Journal:  Can J Vet Res       Date:  1994-10       Impact factor: 1.310

9.  Emergence of a novel avian pox disease in British tit species.

Authors:  Becki Lawson; Shelly Lachish; Katie M Colvile; Chris Durrant; Kirsi M Peck; Mike P Toms; Ben C Sheldon; Andrew A Cunningham
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

10.  Phylogenetic analysis of three genes of Penguinpox virus corresponding to Vaccinia virus G8R (VLTF-1), A3L (P4b) and H3L reveals that it is most closely related to Turkeypox virus, Ostrichpox virus and Pigeonpox virus.

Authors:  Olivia Carulei; Nicola Douglass; Anna-Lise Williamson
Journal:  Virol J       Date:  2009-05-08       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.